BREAST CANCER

BREAST CANCER

Displaying 10 out of 27 results

  1. Chemotherapy

    New breast cancer drug found to boost survival rates by 30%

  2. FILE PHOTO: The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel

    Novartis hopes Kisqali data will help narrow gap to blockbuster rival

    Novartis has released data showing sharply improved overall survival rates for its breast cancer drug Kisqali, which the Swiss drugmaker hopes ...
  3. The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel

    Novartis' breast cancer treatment wins FDA approval

    The U.S. Food and Drug Administration (FDA) said on Friday it approved Novartis AG's treatment in combination with hormone therapy fulvestrant for ...
  4. Fruits and vegetables for sale are seen on a market stall in London

    Healthy diet cuts risk of dying from breast cancer in older women

    A balanced, low-fat diet significantly lowers the risk of dying from breast cancer in postmenopausal women, according to new long-term data from ...
  5. New Content Item

    Weight-loss surgery may help cut risk of breast cancer

  6. The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at th

    AstraZeneca-Daiichi Sankyo breast cancer drug shows promise

    British drugmaker AstraZeneca and Japan's Daiichi Sankyo said on Wednesday their experimental treatment for breast cancer met its key goal in a ...
  7. A woman undergoes a mammogram

    Most women need mammograms every other year starting at 50

  8. FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield

    AstraZeneca pays up to US$6.9 billion in Daiichi Sankyo cancer deal

    AstraZeneca Plc and Japan's Daiichi Sankyo Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Daiichi's cancer ...
  9. New Content Item

    Breast cancer risk tied to DDT varies by exposure timing

  10. Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

    Roche's Tecentriq wins US approval for aggressive breast cancer

    Swiss drugmaker Roche on Friday won U.S. Food and Drug Administration (FDA) approval of its immunotherapy Tecentriq for triple-negative breast ...